Masaaki Sato

Masaaki Sato is a Research Fellow in the Department of Physiology within the Faculty of Pharmacy and Pharm Science at Monash University. His work focuses on the intersection of pharmacology, physiology, and metabolic regulation, particularly examining G-protein coupled receptors and their role in glucose metabolism.

Dr. Sato's primary research interests include pharmacological regulation of glucose uptake, adrenoceptor signaling mechanisms, and metabolic pathways in skeletal muscle and adipose tissue. His work spans molecular pharmacology, receptor biology, and metabolic physiology, with particular emphasis on β-adrenoceptors and their therapeutic potential for metabolic disorders.

Analysis of his publication record from 2005-2024 reveals consistent focus on G-protein coupled receptor signaling in metabolic regulation. His research shows progression from fundamental receptor pharmacology to translational studies examining therapeutic targets for metabolic disorders like diabetes and obesity. Recent work demonstrates increasing sophistication in examining receptor interactions, signaling pathways, and metabolic outcomes.

Scientific Awards:

• ASCEPT Denis Wade Johnson & Johnson New Investigator Award (2015)

Dr. Sato has secured competitive research funding, including a National Health and Medical Research Council (NHMRC) project grant as Chief Investigator for the project "Control of glucose uptake by G-protein coupled receptors" (2010-2014). His research demonstrates sustained productivity with 30 research outputs spanning nearly two decades, indicating successful grant acquisition and research program development. While specific mentoring information isn't provided in the available data, his position as Research Fellow suggests involvement in training junior researchers.

Dr. Sato's work contributes to Sustainable Development Goals related to good health and well-being, particularly in advancing understanding of metabolic disorders and potential therapeutic approaches. His research network shows national and international collaborations focused on receptor pharmacology and metabolic regulation.